# Title
Novel O
functional O
sets O
of O
lipid-derived O
mediators O
with O
antiinflammatory O
actions O
generated O
from O
omega-3 B-Chemical
fatty B-Chemical
acids I-Chemical
via O
cyclooxygenase O
2-nonsteroidal O
antiinflammatory O
drugs O
and O
transcellular O
processing. O

# Abstract
Aspirin B-Chemical
therapy O
inhibits O
prostaglandin B-Chemical
biosynthesis O
without O
directly O
acting O
on O
lipoxygenases, O
yet O
via O
acetylation O
of O
cyclooxygenase B-Gene
2 I-Gene
(COX-2) B-Gene
it O
leads O
to O
bioactive O
lipoxins O
(LXs) O
epimeric O
at O
carbon B-Chemical
15 O
(15-epi-LX, B-Chemical
also O
termed O
aspirin-triggered O
LX B-Disease
[ATL]). B-Disease
Here, O
we O
report O
that O
inflammatory B-Disease
exudates O
from O
mice B-Species
treated O
with O
omega-3 B-Chemical
polyunsaturated I-Chemical
fatty I-Chemical
acid I-Chemical
and O
aspirin B-Chemical
(ASA) B-Chemical
generate O
a O
novel O
array O
of O
bioactive O
lipid B-Chemical
signals. O
Human B-Species
endothelial O
cells O
with O
upregulated O
COX-2 B-Gene
treated O
with O
ASA B-Chemical
converted O
C20:5 B-Chemical
omega-3 B-Chemical
to I-Chemical
18R-hydroxyeicosapentaenoic I-Chemical
acid I-Chemical
(HEPE) B-Chemical
and O
15R-HEPE. B-Chemical
Each O
was O
used O
by O
polymorphonuclear O
leukocytes O
to O
generate O
separate O
classes O
of O
novel O
trihydroxy-containing B-Chemical
mediators, I-Chemical
including O
5-series B-Chemical
15R-LX(5) I-Chemical
and O
5,12,18R-triHEPE. B-Chemical
These O
new O
compounds O
proved O
to O
be O
potent O
inhibitors O
of O
human B-Species
polymorphonuclear O
leukocyte O
transendothelial O
migration O
and O
infiltration O
in O
vivo O
(ATL B-Disease
analogue O
> O
5,12,18R-triHEPE B-Chemical
> O
18R-HEPE). B-Chemical
Acetaminophen B-Chemical
and O
indomethacin B-Chemical
also O
permitted O
18R-HEPE B-Chemical
and O
15R-HEPE B-Chemical
generation O
with O
recombinant O
COX-2 B-Gene
as O
well O
as O
omega-5 O
and O
omega-9 O
oxygenations O
of O
other O
fatty B-Chemical
acids I-Chemical
that O
act O
on O
hematologic O
cells. O
These O
findings O
establish O
new O
transcellular O
routes O
for O
producing O
arrays O
of O
bioactive O
lipid B-Chemical
mediators O
via O
COX-2-nonsteroidal O
antiinflammatory O
drug-dependent O
oxygenations O
and O
cell-cell O
interactions O
that O
impact O
microinflammation. O
The O
generation O
of O
these O
and O
related O
compounds O
provides O
a O
novel O
mechanism(s) O
for O
the O
therapeutic O
benefits O
of O
omega-3 B-Chemical
dietary O
supplementation, O
which O
may O
be O
important O
in O
inflammation, B-Disease
neoplasia, B-Disease
and O
vascular B-Disease
diseases. I-Disease